23 results on '"Sashida, Goro"'
Search Results
2. TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia
3. Stem cell regulation and dynamics in myeloid malignancies
4. The acidic domain of Hmga2 and the domain’s linker region are critical for driving self-renewal of hematopoietic stem cell
5. Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis
6. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma
7. RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner
8. PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome
9. Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation
10. Low prevalence of the BCR–ABL1 fusion gene in a normal population in southern Sarawak
11. Deregulated Polycomb functions in myeloproliferative neoplasms
12. Systematic review of pre-clinical chronic myeloid leukaemia
13. Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
14. Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
15. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
16. Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies
17. Correction to: Systematic review of pre-clinical chronic myeloid leukaemia
18. Epigenetic regulation of hematopoiesis
19. Hepatosplenic αβ T-Cell Lymphoma with Myelodysplastic Syndrome
20. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways
21. Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
22. Telomeres and telomerase in hematologic neoplasia
23. Thrombocytopenia Induced by Imatinib Mesylate (Glivec) in Patients with Chronic Myelogenous Leukemia: is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.